We then chose human breast carcinoma to explore the correlation of the expression levels of SIK with the levels of Par3 and the activity of the TGFβ pathway, measured as levels of phosphorylated Smad2 in the tumor tissue (Supplementary Figure 4A). The gene discussed is SIK1; the disease is breast carcinoma.